Babylon Holdings (NYSE:BBLN) reported quarterly losses of $(4.50) per share which missed the analyst consensus estimate of $(4.42) by 1.81 percent. This is a 72.31 percent increase over losses of $(16.25) per share from
Babylon (NYSE:BBLN) ("Babylon'') today announced additional details concerning the previously announced 1-for-25 reverse share split (the "Reverse Share Split") of its Class A ordinary shares,
Gainers
Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.